[1] Gorse GJ, O'connor TZ, Young SL, et al. Impact of a winter respiratory virus season on patients with COPD and association with influenza vaccination[J]. Chest, 2006, 130(4): 1109-1116. [2] 衡永波,吴灵兵,陈桂明,等.热毒宁治疗小儿手足口病52 例疗效观察[J].现代中西医结合杂志, 2010, 19(8): 949-950. [3] 孙广信, 祖育娜, 李国燕. 热毒宁注射液辅助治疗重症肺炎的临床研究[J]. 实用药物与临床, 2012, 15(7): 439-440. [4] Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease (update2010)[EB/OL]. Available from: http://www.goldcopd. org/ Guidelines/guideline-2010-gold-report.html. [5] Mahler DA, Weinberg DH, Wells CK, et al. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes[J]. Chest, 1984, 85(6): 751-758. [6] Kinnula VL, Ilumets H, Myllärniemi M, et al. 8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD[J]. Eur Respir J, 2007, 29(1): 51-55. [7] Rohde G, Wiethege A, Borg I, et al. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study[J]. Thorax, 2003, 58(1): 37-42. [8] Baz M, Abed Y, Papenburg J, et al. Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis[J]. N Engl J Med, 2009, 361(23): 2296-2297. [9] 周颖, 金前, 柴秀娟. 福多司坦治疗慢性阻塞性肺疾病急性加重患者的临床观察[J] . 中国临床药理学与治疗学, 2012,17(3): 334-337. [10]Mahler DA, Waterman LA, Ward J, et al. Validity and responsiveness of the self-administered computerized versions of the baseline and transition dyspnea indexes[J]. Chest, 2007, 132(4): 1283-1290. [11]徐秀丽, 朱桂花, 唐杰. 热毒宁的药理作用与临床应用[J]. 社区医学杂志, 2011, 9(1): 23-24. [12]冯旰珠, 周锋, 黄茂, 等. 热毒宁对流感病毒FM1 的抑制作用[J]. 中国新药与临床杂志, 2007, 26(9): 663-667 [13]鄢莉宏, 陈云天, 陈小东, 等. 慢性阻塞性肺疾病稳定期患者呼吸道合胞病毒感染与气道炎症的关系[J]. 中国老年学杂志, 2010, 30(20): 2900-2902. [14]Yageta Y, Ishii Y, Morishima Y, et al. Role of Nrf2 in host defense against influenza virus in cigarette smoke-exposed mice[J]. J Virol, 2011, 85(10): 4679-4690. |